Home Technology New Startups, Financing, Mergers, Clinical Trials, Partnerships - GeekWire

New Startups, Financing, Mergers, Clinical Trials, Partnerships – GeekWire

A protein (purple) interacting with a small molecule, a potential drug (green), visualized in Charm Therapeutics’ DragonFold tool. (Charm image)

Here’s a rundown of life sciences and health news in the Pacific Northwest this week.

Partnerships:

  • Seattle-based DNA sequencing companies TwinStrand Biosciences and Singular Genomics have teamed up to develop ultra-sensitive tests to detect rare gene variants. One application is the detection of “minimal residual disease” in cells and tumor DNA in the bloodstream.
  • Seattle’s Umoja Biopharma and TreeFrog Therapeutics combine technology to create new cell therapies from human-induced pluripotent stem cells, raw cells that can be pushed into different cell types. Umoja has a way of turning these cells into therapeutic immune cells, and TreeFrog can grow them in large quantities.

American Society of Clinical Oncology (ASCO) summaries:

Clinical Trials:

  • People between the ages of six months and 49 years will be assessed in a study asking how well COVID-19 vaccines protect against disease, especially in children, and how the immune system responds after infection. The multi-center study will enroll 3,500 people in the Seattle and Portland areas.
  • Cell therapy company Sonoma Biotherapeutics has been given the green light from the US Food and Drug Administration for an early trial of its biological SBT115301. SBT115301 is designed to eliminate highly active immune cells present in autoimmune and inflammatory diseases in preparation for treatment with cells derived from immune-soothing “regulatory” T cells.

publications:

  • Seattle Children’s Research Institute researchers and their colleagues rated isoflurane, a general anesthetic. The gas inhibits an important protein complex in mitochondria, the cell’s energy-producing factories, leading to effects on neurons.
  • Baker, head of the UW’s Institute for Protein Design, and his colleagues wrote a review article: Nature investigating how efficient enzymes can be designed from scratch.

New production center:

  • Swiss biomanufacturing giant Lonza has expanded its facility in Bend, Oregon, with a new center focused on enhancing the delivery of oral or inhaled small molecules.

Closed for business:

  • Washington State Attorney General Bob Ferguson won $500,000 for people who paid for unproven stem cell treatments from a company that ran the Seattle Stem Cell Center, which is no longer allowed to market such treatments.

Events and deadlines:

RELATED ARTICLES

Queen’s Platinum Jubilee: Daniele Hamamdjian Reflects

As Queen Elizabeth II sat on the throne for 70 years, thousands and thousands took to the streets of central London to celebrate the...

Jimmy Eat World and The Maine Team Up for a Big Phoenix Concert

Alt-rock outfits Jimmy Eat World and The Maine are arguably two of the biggest acts to emerge from Phoenix in recent decades. And they’ve...

Missing boy found alive after surviving 8 days in German sewer – National

An eight-year-old boy has been found alive after going missing and surviving eight days in a sewage system in northwestern Germany. The boy, who is...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Queen’s Platinum Jubilee: Daniele Hamamdjian Reflects

As Queen Elizabeth II sat on the throne for 70 years, thousands and thousands took to the streets of central London to celebrate the...

Jimmy Eat World and The Maine Team Up for a Big Phoenix Concert

Alt-rock outfits Jimmy Eat World and The Maine are arguably two of the biggest acts to emerge from Phoenix in recent decades. And they’ve...

Missing boy found alive after surviving 8 days in German sewer – National

An eight-year-old boy has been found alive after going missing and surviving eight days in a sewage system in northwestern Germany. The boy, who is...

Ottawa transit ridership at 50 percent of pre-pandemic levels in May

Passenger numbers on OC Transpo buses and the O-Train were 50 percent from pre-pandemic levels in May as Ottawa’s transit service continues to operate...